The end of the best-selling prescription medication causes pain - 'Outrageous price'
The shortage of the widely-used anticoagulant apixaban in Finland has led to significant distress due to skyrocketing prices and limited access, caused by a patent dispute among pharmaceutical companies.
UK, US drug pricing deal to cost £1bn over three years
A new UK-US pharmaceutical agreement will result in the National Health Service incurring costs of £1 billion over the next three years due to increased medicine prices and tariff exemptions.